V6
General Information
DRACP ID DRACP00117
Peptide Name V6
Sequence CFKFKFKFGSGFKFKFKFC
Sequence Length 19
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
THP-1 | Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia | Leukemia | IC50=45 µM | CellTiter 96 AQueous One Solution assay | 1 h | 1 |
Hemolytic Activity Human erythrocytes: 50% Hemolysis=35 µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond Cys1<--->Cys19
N-terminal Modification Acetylization
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C121H167N25O21S2
Absent amino acids ADEHILMNPQRTVWY
Common amino acids F
Mass 269315
Pl 10.8
Basic residues 6
Acidic residues 0
Hydrophobic residues 8
Net charge 6
Boman Index -842
Hydrophobicity 12.63
Aliphatic Index 0
Half Life
Mammalian: 1.2 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 125
Absorbance 280nm 6.94
Polar residues 5
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 15328096
Title De novo design of potent antimicrobial peptides
Doi 10.1128/AAC.48.9.3349-3357.2004
Year 2004
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available